Latest News and Press Releases
Want to stay updated on the latest news?
-
Global Will be Using All CLIA WAIVED Lab to Test for COVID 19 Antigen, Antibody, and the Other 15 Tests that are CLIA WAIVED that Global Carries; Company is Bringing Testing to Patients at Schools...
-
SAN CLEMENTE, CA, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests attains...
-
SAN CLEMENTE, CA, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains...
-
Single-Dose Oxford–AstraZeneca COVID-19 Vaccine Followed by a 12-Week Booster SAN CLEMENTE, CA, March 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp (OTC: GWHP)...
-
Global Wholehealth Partners Corp. is Preparing Itself to be the First Fully Green Medical Device Supplier, by Using Biodegradable Plastics for All Cassettes, Midstream, Urine Cups and Other Testing...
-
Antigen Testing is Essential to Keep the Fight Against CoViD19 SARS 2 SAN CLEMENTE, CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners...
-
Global's Antibody Test Can Detect the New CoViD 19 SARS 2 Strain SAN CLEMENTE, CA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners Corp...
-
SAN CLEMENTE, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (GWHP) announces it had submitted an Emergency Use Authorization (EUA) Application...
-
SAN CLEMENTE, CA, Aug. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC Pink: GWHP) today announced Goldman Small Cap Research has published an initial analyst...
-
SAN CLEMENTE, CA, Aug. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC PINK: GWHP) announced today that it is authorized to sell FDA EUA Authorized SARS-COV-2...